We are thrilled to have Rachel Ochs-Ross, M.D., J.D. join our Board as co-chair. She is an experienced Neurologist who has extensive experience guiding all phases of clinical drug development, from early compound assessment through Phase IV clinical studies and has...
Please join the Circle City Chapter of Association of Clinical Research Professionals for their upcoming speaking event TOPIC: FDA Form 483’s & FDA Warning Letters Involving Clinical Drug Trials Issued in 2010: What We Can Learn Presented by David Finch, CCRP,...
Oprah, House and Garden TV, home magazines; they are all hot on the de-clutter bug. Even the FDA is stepping in. Last Wednesday FDA announced that many unapproved cough/cold and allergy medicines would be removed from the market. ...
Barnes & Thornburg LLP and Pearl IRB invite you to join us for a special event focused on the regulatory aspects of clinical research. FEATURED PRESENTATIONS: “Responsibilities of the Site and Clinical Research Principal Investigator: myths and the reality,”...
Check out the new forms recently posted under the Resources section of the website. You’ll find several forms here to use when you are having your study reviewed. Don’t see something you need? Send us an email at forms@pearlirb.com and we we’ll...
Gretchen Miller Bowker, COO, Pearl IRB is speaking at the IMDMC regulatory roundtable “Effectively Managing Multi-Center Trials” – REGISTER NOW! Speakers: Jennifer L. Kerr, VP of Operations MED Institute, Inc. Jenna Sallee, Executive Director...
